Cytology Devices Market Overview
Cytology refers to a branch of pathology, the medical specialty that deals with making diagnoses of diseases and conditions through the examination of tissue samples from the body. Cytology is one of the leading diagnostic methods used for the detection of cancer. The global Cytology Devices market is expected to expand at a significant rate in the forthcoming years. The high prevalence of cancer across the world is projected to increase the adoption of cytology devices for conducting cytology tests. This key factor majorly contributes to the growth of the global Cytology Devices market. According to World Health Organization, Cancer is a leading cause of death worldwide, accounting for nearly 10 million deaths in 2020.
Furthermore, technical progressions in the field of cytology such as automated cytology analyzers and point-of-care testing devices are expected to propel the cytology devices market during the forecast period. In addition, increasing efficiency and availability of advanced collection devices such as aspiration needles for the collection of liver and pancreas specimens is anticipated to fuel the cytology devices market in the coming years.
On the downside, the availability of low-quality and inexpensive cytology devices in regional marketplaces is projected to hamper the cytology devices market. In addition to this, rising developments in alternative therapies such as immunoassays and molecular diagnostics are likely to hamper the market’s growth in the forthcoming years. Covid-19 Impact on Cytology Devices Market:
In addition, the current Cytology Devices Market study offers a detailed analysis of the current COVID-19 pandemic impact on the market growth and its influence on the future growth of the Cytology Devices Market. The recently published report demonstrates the elevation in the demand for the healthcare sector. The healthcare manufacturers have experienced long term as well as short term effect which includes supply shortages, panic buying, and stocking, regulation changes as short-term whereas approval delays and possible trend variations in consumption could be perceived as long-term impacts of COVID-19 on the health and pharmaceutical market.
The increasing need for a cure has pushed vaccine research and manufacturers to the limit. In addition to this, panic conditions have already spurred the demand for many healthcare products and services which are discussed in detail in this report. Moreover, the impact of COVID-19 on overall market revenue for the base year 2020 and its projection up to 2027 is provided in detail in this report.Cytology Devices Market Segment Overview
According to the product, the brushes segment is expected to hold the largest share of the global cytology devices market over the forecast period. Also, the aspiration needles segment has the significant growth in the market in the forecast period, due to their rising usage in the collection of liver, pancreas, and breast specimens as well as plural fluids and spinal fluids.
Based on application, the gynecology segment has noteworthy growth in the market. This is because of the high prevalence of cervical cancer and the launch of new products for the treatment of cervical cancer. Furthermore, technological developments in the field of gastroenterology such as new endoscopy systems and ultrasound endoscopy are expected to contribute to the high growth of the gastroenterology segment.
Cytology Devices Market, By Product
- Aspiration Needles
Cytology Devices Market, By Application
Cytology Devices Market, By End User
· Ambulatory Surgical Centers
· Diagnostic Laboratories
· OthersCytology Devices Regional Overview
In terms of region, North America commanded a major share of the Cytology Devices market and is predictable to maintain its supremacy over the forecast period. This is because of the high number of cytology tests being performed in the region. Moreover, Europe is anticipated to account for a significant share of the global market. This is mainly due to increasing incidences of cancer in this region. Similarly, the market in the Asia Pacific is expected to witness high growth during the forecast period, owing to increasing health care expenditure in the region.
Cytology Devices Market, By Geography
· North America (US & Canada)
· Europe (UK, Germany, France, Italy, Spain, Russia & Rest of Europe)
· Asia-Pacific (Japan, China, India, Australia, & South Korea, & Rest of Asia-Pacific)
· LAMEA (Brazil, Saudi Arabia, UAE & Rest of LAMEA)Cytology Devices Market Competitor overview
Some key developments and strategies adopted by manufacturers in Cytology Devices are highlighted below.
· In July 2021, AnchorDx, a world-leading developer of cancer screening and early detection solutions was awarded a Breakthrough Device Designation ("BTD") by the US Food and Drug Administration (FDA) for UriFind (or "the Test"), an early detection test for bladder cancer based on urine DNA methylation detection. This is the first BTD granted to liquid biopsy test for bladder cancer detection in China. Cytology Devices Market, Key Players
· Biocytech Corporation
· RI.MOS. srl
· CONMED Corporation
· Olympus Corporation
· MEDI-GLOBE CORPORATION
· US Endoscopy (a part of STERIS Corporation)
· ENDO-FLEX GmbH
· STERYLAB S.r.l.
Data Library Research are conducted by industry experts who offer insight on
industry structure, market segmentations technology assessment and competitive landscape (CL), and penetration, as well as on emerging trends. Their analysis is based on primary interviews (~ 80%) and secondary research (~ 20%) as well as years of professional expertise in their respective industries. Adding to this, by analysing historical trends and current market positions, our analysts predict where the market will be headed for the next five years. Furthermore, the varying trends of segment & categories geographically presented are also studied and the estimated based on the primary & secondary research.
In this particular report from the supply side Data Library Research has conducted primary surveys (interviews) with the key level executives (VP, CEO’s, Marketing Director, Business Development Manager
and SOFT) of the companies that active & prominent as well as the midsized organization
FIGURE 1: DLR RESEARH PROCESS
Extensive primary research was conducted to gain a deeper insight of the market and industry performance. The analysis is based on both primary and secondary research as well as years of professional expertise in the respective industries.
In addition to analysing current and historical trends, our analysts predict where the market is headed over the next five years.
It varies by segment for these categories geographically presented in the list of market tables. Speaking about this particular report we have conducted primary surveys (interviews) with the key level executives (VP, CEO’s, Marketing Director, Business Development Manager and many more) of the major players active in the market.
Secondary research was mainly used to collect and identify information useful for the extensive, technical, market-oriented, and Friend’s study of the Global Extra Neutral Alcohol. It was also used to obtain key information about major players, market classification and segmentation according to the industry trends, geographical markets, and developments related to the market and technology perspectives. For this study, analysts have gathered information from various credible sources, such as annual reports, sec filings, journals, white papers, SOFT presentations, and company web sites.
Market Size Estimation
Both, top-down and bottom-up approaches were used to estimate and validate the size of the Global market and to estimate the size of various other dependent submarkets in the overall Extra Neutral Alcohol. The key players in the market were identified through secondary research and their market contributions in the respective geographies were determined through primary and secondary research.